Skip to content
ClinCalc Pro
Menu
Alcohol Deterrent (Aldehyde Dehydrogenase Inhibitor)

Disulfiram

Brand names: Antabuse

Disulfiram is an aversive agent used as an adjunct in the maintenance of abstinence in alcohol dependence.

Dosing — being independently re-sourced

ClinCalc Pro is rebuilding its dose data from primary open sources — the manufacturer SmPC (eMC), the WHO Model Formulary and other official references — under clinician review. This drug's structured dose is not yet published here. Confirm all doses against the product SmPC and your local formulary before prescribing.

Clinical monograph

How it works

It irreversibly inhibits aldehyde dehydrogenase, causing accumulation of acetaldehyde if alcohol is consumed, which produces an unpleasant flushing, headache, nausea and palpitation reaction that deters drinking.

Prescribing in practice

  • A severe and potentially fatal reaction can occur with even small amounts of alcohol, including that in foods, medicines and toiletries, so patient understanding and supervision are essential.
  • Contraindicated in cardiovascular disease, severe psychiatric illness and during pregnancy because of the risk of the alcohol-disulfiram reaction.
  • Rare hepatotoxicity has been reported, so liver function should be checked and the drug stopped if hepatic dysfunction develops.

Monitoring

Monitor liver function and blood pressure during treatment and review adherence and abstinence regularly.

Counselling the patient

  • Avoid all alcohol, including in foods, mouthwashes and over-the-counter medicines, throughout treatment and for a period after stopping.
  • Seek urgent help if you experience chest pain, severe flushing or breathlessness.
  • Treatment works best alongside psychological support and supervised administration.

Evidence & guidelines

Disulfiram is an established option for supervised relapse prevention, and NICE recommends it as an adjunct alongside psychosocial support in alcohol dependence.

Reference: NICE CG115 (Alcohol Dependence); NICE NG115; Drug verified in RxNorm (NLM); confirm dosing against the manufacturer SPC (eMC). Verify against your local formulary and current prescribing references before prescribing. Monograph status: clinician-reviewed (2026-07-04).

Related

Curated clinical cross-links plus same-class fallbacks.